Theresa Deisher
Principal investigator, leads Avm Biotechnology, LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$4.5MFederal grants as PI5 awards
6Patents grantedLatest Jun 16, 2026
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $4.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 5, 2022 | NIH | SBIR Phase I AVM0703 combined with Non-Hodgkin's Lymphoma standard of care to enhance complete response rates without additional toxicities | $399K | Avm Biotechnology, LLC |
| Jun 10, 2022 | NIH | SBIR Phase II Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients | $2.0M | Avm Biotechnology, LLC |
| Apr 1, 2022 | NIH | SBIR Phase II Targeted Lymphoablation as an alternative to HSCT to cure T1D | $1.6M | Avm Biotechnology, LLC |
| Jul 1, 2020 | NIH | SBIR Phase I A novel non-toxic preconditioning regimen for cancer cell therapy | $225K | Avm Biotechnology, LLC |
| Sep 20, 2019 | NIH | SBIR Phase I Targeted lympho-ablation as an alternative to HSCT to cure T1D | $211K | Avm Biotechnology, LLC |
7 patents as inventor
- US 10426740Avm Biotechnology, LLCOct 1, 2019
- US 11219628Avm Biotechnology, LLCJan 11, 2022
- US 11446314Avm Biotechnology, LLCSep 20, 2022
- US 12048705Avm Biotechnology, LLCJul 30, 2024
- US 12648952Avm Biotechnology, LLCJun 9, 2026
- US 12653891Avm Biotechnology, LLCJun 16, 2026
- US Avm Biotechnology, LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#329
Awards as PI#417
Patents#15
Companies
- Avm Biotechnology, LLCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.